Antisense c-mycInhibition of Lymphoma Growth

This publication has 16 references indexed in Scilit:

• Rapid Measurement of Modified Oligonucleotide Levels in Plasma Samples with a Fluorophore Specific for Single-Stranded DNA
  Antisense and Nucleic Acid Drug Development, 1997
• The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
  Proceedings of the National Academy of Sciences, 1995
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.
  Circulation, 1994
• Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1
  Biochemical Pharmacology, 1993
• Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
  Proceedings of the National Academy of Sciences, 1988
• The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
  The Journal of Experimental Medicine, 1988
• A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
  Nature, 1987
• Oligodeoxynucleotide stability in subcellular extracts and culture media
  Journal of Biochemical and Biophysical Methods, 1986
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
  Nature, 1985